SubHero Banner
Text

April 2024

Core topics in this month’s edition include:

  • Pivya (pivmecillinam) - new drug approval 
  • Tyenne (tocilizumab-aazg) – first-time biosimilar launch
  • Zevtera (ceftobiprole medocaril sodium) – new drug approval

Download PDF

Text